DGX vs GPCR · P/E 22, rev $5.94B vs $1.09B cap
Quest Diagnostics Incorporated (DGX) versus Structure Therapeutics Inc. American Depositary Shares (GPCR) — a side-by-side from cached financials, not a winner call.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
Structure Therapeutics Inc. American Depositary Shares (GPCR) is a biotechnology company listed on US.
Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
GPCR does not have a complete income-statement cache yet.
DGX currently screens at market cap $19.94B and trailing P/E 22.4. GPCR currently screens at market cap $1.09B.
Not investment advice. Open the DGX and GPCR stock pages for the full models.
Not investment advice.